NCLAT sets aside NCLT order to liquidate Sterling Biotech

05 Sep 2019

The National Company Law Appellate Tribunal (NCLAT) has set aside the National Company Law Tribunal (NCLT) order to liquidate Sterling Biotech, and directed that the management should be handed over to its promoters if the dues of creditors are settled. Promoters of the company include absconding Nitin Jayantilal Sandesara and Chetankumar Jayantilal Sandesara.

Sterling Biotech is engaged in manufacturing of pharmaceutical and nutraceutical gelatin.

Related Sterling Biotech Ltd. Links:

Sterling Biotech Share Price

0.77 0.00 (0.00%) Nov 05, 17:59
1 Year Price Chart
Peers
Company Name CMP
Tata Chemicals 639.95
Pidilite Inds. 1297.60
Aarti Inds 826.35
Atul 4102.75
Jubilant LifeScience 516.80
View more..
Sensex vs Sterling Biotech
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463